Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001600132-18-000062
Filing Date
2018-05-17
Accepted
2018-05-17 08:48:18
Documents
5
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A blph-12312017x10ka.htm 10-K/A 921364
2 EXHIBIT 23.1 blph-12312017x10kaex231.htm EX-23.1 4120
3 EXHIBIT 31.1 blph-12312017x10kaex311.htm EX-31.1 11973
4 EXHIBIT 31.2 blph-12312017x10kaex312.htm EX-31.2 11978
5 EXHIBIT 32 blph-12312017x10kaex32.htm EX-32 7908
  Complete submission text file 0001600132-18-000062.txt   958457
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36845 | Film No.: 18841811
SIC: 2834 Pharmaceutical Preparations